Delivery Order SPE2DB24D2208-SPE2DB25FHJFK
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,950.76 for Candesartan Cilexetil 8 mg tablets (90-count) on September 2, 2025, with completion targeted for September 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a $1,113.48 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Candesartan Cilexetil 8 mg tablets (90-count) with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger federal contracting relationship. The pharmaceutical will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,337.06 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count) on June 2, 2025, with completion scheduled for June 3, 2025. This delivery order was issued under a firm fixed-price contract structure with no set-aside designation, indicating competitive award. The product will be performed from AmerisourceBergen's Conshohocken, Pennsylvania location, the company's corporate headquarters...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,350.69 on September 16, 2025, for the supply of Candesartan Cilexetil 8 mg tablets (90-count). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 17, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $1,584.07 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count) on June 18, 2025, with completion scheduled for June 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $1,060.74 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 8 mg tablets (90-count) with a firm fixed price structure. The award was made on September 5, 2025, with an ultimate completion date of September 8, 2025, and represents a non-set-aside, competitively awarded contract. Performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles) with a ceiling value of $1,175.41. This firm fixed-price delivery order, with an ultimate completion date of August 22, 2025, represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $9,133.43 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Candesartan Cilexetil 8 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of August 15, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary operations facility. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles) with a ceiling value of $10,879.54. This firm fixed-price delivery order, with an ultimate completion date of September 11, 2025, was competitively awarded without set-aside designation. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count) with a ceiling value of $102,998.84. This firm fixed-price delivery order, with an ultimate completion date of June 2, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- SPE2DB24D2208Indefinite Delivery Contract
- SPE2DB24D2208-SPE2DB25FHJFKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $16,479.99 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 8 mg tablets (90-count) on September 18, 2025, with completion expected by September 19, 2025. This delivery order was competitively awarded without any set-aside designation and utilizes firm fixed pricing. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is issued under AmerisourceBergen Drug Corp's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. The arrangement reflects the Defense Logistics Agency's reliance on established vendor relationships to efficiently fulfill ongoing pharmaceutical procurement needs for the Department of Defense and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.5k | 9/18/25 |